Evidence map›Paper›PMID 35545088›Full record

ReviewCell metabolism2022

The crosstalk between bone remodeling and energy metabolism: A translational perspective.

Gerard Karsenty, Sundeep Khosla

Open access · bronzeAbstract readReview
In one paragraph

Review in Cell metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
9.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 99 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. The Intimate Relationship between Adipose Tissue, Fertility, and Bone.Journal of frailty, sarcopenia and falls · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Gerard KarsentyDepartment of Genetics and Development, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA. Electronic address: gk2172@cumc.columbia.edu.
Sundeep KhoslaKogod Center of Aging and Division of Endocrinology and Metabolism, Mayo Clinic College of Medicine and Science, Rochester, MN, USA. Electronic address: khosla.sundeep@mayo.edu.
Columbia University · USMayo Clinic · US

Funding

Transcriptomic CoreP01AG032959 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Gerard Karsenty · 2010 to 2026
$39.7M
Targeting Cellular Senescence to Extend HealthspanP01AG062413 · NIA · MAYO CLINIC ROCHESTER · PI Sundeep Khosla · 2019 to 2026
$28.7M
Beta1-selective blockade for prevention of postmenopausal bone loss: A randomized controlled trialR01AG065154 · NIA · MAYO CLINIC ROCHESTER · PI BLACK, DENNIS M, KHOSLA, SUNDEEP · 2021 to 2025
$12.0M
Muscle regulation of bone functionR01AR073180 · NIAMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI KARSENTY, GERARD · 2019 to 2023
$2.5M
A Neuronal Basis for the Osteocalcin Regulation of Bone MassR01DE027887 · NIDCR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI KARSENTY, GERARD · 2018 to 2022
$1.9M
NIAMS NIH HHS R01 AR073180NIA NIH HHS P01 AG032959NIA NIH HHS P01 AG062413NIA NIH HHS R01 AG065154NIDCR NIH HHS R01 DE027887
6 · The paper itself

Abstract

Genetics in model organisms has progressively broken down walls that previously separated different disciplines of biology. One example of this holistic evolution is the recognition of the complex relationship that exists between the control of bone mass (bone remodeling) and energy metabolism in mammals. Numerous hormones orchestrate this crosstalk. In particular, the study of the leptin-mediated regulation of bone mass has not only revealed the existence of a central control of bone mass but has also led to the realization that sympathetic innervation is a major regulator of bone remodeling. This happened at a time when the use of drugs aiming at treating osteoporosis, the most frequent bone disease, has dwindled. This review will highlight the main aspects of the leptin-mediated regulation of bone mass and how this led to the realization that β-blockers, which block the effects of the sympathetic nervous system, may be a viable option to prevent osteoporosis.

Indexed as

LeptinOsteoporosisAnimalsBone DensityBone RemodelingEnergy MetabolismMammalsSympathetic Nervous SystemLeptincoordinated regulation of bone mass and energy metabolismosteoporosissympathetic regulation of bone massβ-blockers

Identifiers

PMID35545088
PMCPMC9535690
OpenAlexW4280530929

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.